Financhill
Buy
65

RLAY Quote, Financials, Valuation and Earnings

Last price:
$8.66
Seasonality move :
-13.11%
Day range:
$8.31 - $8.76
52-week range:
$1.78 - $9.04
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
176.04x
P/B ratio:
2.47x
Volume:
866.5K
Avg. volume:
2.3M
1-year change:
104.49%
Market cap:
$1.5B
Revenue:
$10M
EPS (TTM):
-$1.75

Earnings Data

Next earnings date for RLAY
Feb 25
2026
Most recent earnings per share
-$0.43
Missed by $0.01
(Nov 6/2025)
Consensus Estimate
-$0.42
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RLAY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $5M -- -- -$0.40 --
11/06/2025 Q3 $160K -- -$0.43 -$0.42 -$0.01
08/07/2025 Q2 $75K $677K -$0.41 -$0.47 $0.06
05/05/2025 Q1 $11.1K $7.7M -$0.46 -$0.48 $0.02
02/26/2025 Q4 $5.5M -- -$0.45 -$0.55 $0.09
11/06/2024 Q3 $80K -- -$0.63 -$0.78 $0.16
08/06/2024 Q2 $88.9K -- -$0.69 -$0.73 $0.03
05/02/2024 Q1 $109.1K $10M -$0.62 -$0.69 $0.07
02/22/2024 Q4 $610K -- -$0.67 -$0.77 $0.10
11/02/2023 Q3 $412K $25.2M -$0.54 -$0.86 $0.32
08/08/2023 Q2 -- $119K -$0.81 -- --
05/04/2023 Q1 -- $226K -$0.78 -- --
02/23/2023 Q4 -- $253K -$0.56 -- --
11/03/2022 Q3 -- $344K -$0.76 -- --
08/04/2022 Q2 -- $365K -$0.71 -- --
05/05/2022 Q1 -- $419K -$0.57 -- --
02/24/2022 Q4 -- $567K -$0.62 -- --
11/10/2021 Q3 -- $666K -$0.66 -- --
08/12/2021 Q2 -- $844K -$2.10 -- --
05/13/2021 Q1 -- $952K -$0.47 -- --
03/25/2021 Q4 -- $82.7M $0.39 -- --
11/12/2020 Q3 -- -- -$2.38 -- --
08/27/2020 Q2 -- -- -$0.30 -- --
03/31/2020 Q1 -- -- -$0.28 -- --
12/31/2019 Q4 -- -- -$0.27 -- --
09/30/2019 Q3 -- -- -$0.22 -- --
06/30/2019 Q2 -- -- -$0.19 -- --
03/31/2019 Q1 -- -- -$0.16 -- --

Relay Therapeutics, Inc. Earnings Questions

  • How Much did Relay Therapeutics, Inc. Generate in Revenue Last Quarter?

    Relay Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Relay Therapeutics, Inc. Beat Earnings Last Quarter?

    Relay Therapeutics, Inc. announced earnings per share of -$0.43 which represents a miss of analyst forecast a -$0.42 per share.

  • Is Relay Therapeutics, Inc. Profitable?

    Relay Therapeutics, Inc. reported -$748K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Relay Therapeutics, Inc. EPS Next Year?

    Relay Therapeutics, Inc.'s earnings are forecast to decrease from -$2.36 per share to -$2.47 per share next year representing a decrease of -26.28%.

  • When is Relay Therapeutics, Inc.'s Earnings Date?

    Relay Therapeutics, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
56
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock